BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 31296454)

  • 1. Occupational safety of pressurized intraperitoneal aerosol chemotherapy (PIPAC) in an operating room without laminar airflow.
    Delhorme JB; Klipfel A; D'Antonio F; Greget MC; Diemunsch P; Rohr S; Romain B; Brigand C
    J Visc Surg; 2019 Dec; 156(6):485-488. PubMed ID: 31296454
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pressurized intraperitoneal aerosol chemotherapy (PIPAC): occupational health and safety aspects.
    Solass W; Giger-Pabst U; Zieren J; Reymond MA
    Ann Surg Oncol; 2013 Oct; 20(11):3504-11. PubMed ID: 23765417
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Occupational exposure to cisplatin/oxaliplatin during Pressurized Intraperitoneal Aerosol Chemotherapy (PIPAC)?
    Ametsbichler P; Böhlandt A; Nowak D; Schierl R
    Eur J Surg Oncol; 2018 Nov; 44(11):1793-1799. PubMed ID: 29871821
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessment of workplace environmental contamination and occupational exposure to cisplatin and doxorubicin aerosols during electrostatic pressurized intraperitoneal aerosol chemotherapy.
    Roussin F; Taibi A; Canal-Raffin M; Cantournet L; Durand-Fontanier S; Druet-Cabanac M; El Balkhi S; Maillan G
    Eur J Surg Oncol; 2021 Nov; 47(11):2939-2947. PubMed ID: 34034944
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Severe hypersensitivity reactions to platinum compounds post-pressurized intraperitoneal aerosol chemotherapy (PIPAC): first literature report.
    Siebert M; Alyami M; Mercier F; Gallice C; Villeneuve L; Bérard F; Glehen O; Bakrin N; Kepenekian V
    Cancer Chemother Pharmacol; 2019 Mar; 83(3):425-430. PubMed ID: 30511218
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Occupational safety of pressurized intraperitoneal aerosol chemotherapy (PIPAC).
    Willaert W; Sessink P; Ceelen W
    Pleura Peritoneum; 2017 Sep; 2(3):121-128. PubMed ID: 30911641
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pressurized intraperitoneal aerosol chemotherapy (PIPAC) for unresectable peritoneal metastasis from gastric cancer.
    Alyami M; Bonnot PE; Mercier F; Laplace N; Villeneuve L; Passot G; Bakrin N; Kepenekian V; Glehen O
    Eur J Surg Oncol; 2021 Jan; 47(1):123-127. PubMed ID: 32561204
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Safety and feasibility of pressurized intraperitoneal aerosol chemotherapy (PIPAC) associated with systemic chemotherapy: an innovative approach to treat peritoneal carcinomatosis.
    Robella M; Vaira M; De Simone M
    World J Surg Oncol; 2016 Apr; 14():128. PubMed ID: 27125996
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Perioperative safety of intraperitoneal aerosol chemotherapy : Analysis of our first 111 pressurized intraperitoneal aerosol chemotherapy (PIPAC) procedures].
    Jansen-Winkeln B; Thieme R; Haase L; Niebisch S; Pommer C; Lyros O; Zimmer J; Lordick F; Remane Y; Frontini R; Gockel I
    Chirurg; 2019 Feb; 90(2):137-145. PubMed ID: 29947920
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Current practice of pressurized intraperitoneal aerosol chemotherapy (PIPAC): Still standardized or on the verge of diversification?
    Sgarbura O; Villeneuve L; Alyami M; Bakrin N; Torrent JJ; Eveno C; Hübner M;
    Eur J Surg Oncol; 2021 Jan; 47(1):149-156. PubMed ID: 32900609
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Occupational exposure to platinum drugs during intraperitoneal chemotherapy. Biomonitoring and surface contamination.
    Ndaw S; Hanser O; Kenepekian V; Vidal M; Melczer M; Remy A; Robert A; Bakrin N
    Toxicol Lett; 2018 Dec; 298():171-176. PubMed ID: 29852276
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of the environmental contamination and exposure risk in medical/non-medical staff after oxaliplatin-based pressurized intraperitoneal aerosol chemotherapy.
    Larroque M; Arnaudguilhem C; Bouyssiere B; Quenet F; Bouazza N; Jarlier M; Boulabas S; Mounicou S; Sgarbura O
    Toxicol Appl Pharmacol; 2021 Oct; 429():115694. PubMed ID: 34428445
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Concentrations of cisplatin and doxorubicin in ascites and peritoneal tumor nodules before and after pressurized intraperitoneal aerosol chemotherapy (PIPAC) in patients with peritoneal metastasis.
    Tempfer CB; Hilal Z; Dogan A; Petersen M; Rezniczek GA
    Eur J Surg Oncol; 2018 Jul; 44(7):1112-1117. PubMed ID: 29753612
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pressurized Intraperitoneal Aerosol Chemotherapy (PIPAC) with Low-Dose Cisplatin and Doxorubicin in Gastric Peritoneal Metastasis.
    Nadiradze G; Giger-Pabst U; Zieren J; Strumberg D; Solass W; Reymond MA
    J Gastrointest Surg; 2016 Feb; 20(2):367-73. PubMed ID: 26511950
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pressurized intraperitoneal aerosol chemotherapy (PIPAC) of peritoneal metastasis from gastric cancer: a descriptive cohort study.
    Ellebæk SB; Graversen M; Detlefsen S; Lundell L; Fristrup CW; Pfeiffer P; Mortensen MB
    Clin Exp Metastasis; 2020 Apr; 37(2):325-332. PubMed ID: 32002724
    [TBL] [Abstract][Full Text] [Related]  

  • 16. First Clinical Safety and Feasibility Data of Whole-body Hyperthermia Pressurized Intraperitoneal Aerosol Chemotherapy (WBH-PIPAC) for Peritoneal Surface Malignancies.
    Kockelmann F; Giger-Pabst U; Ouaissi M; Bucur P; Barbey S; VON Ardenne A; Zieren J
    Anticancer Res; 2024 Jul; 44(7):3043-3050. PubMed ID: 38925817
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Systemic chemotherapy and pressurized intraperitoneal aerosol chemotherapy (PIPAC): A bidirectional approach for gastric cancer peritoneal metastasis.
    Di Giorgio A; Schena CA; El Halabieh MA; Abatini C; Vita E; Strippoli A; Inzani F; Rodolfino E; Romanò B; Pacelli F; Rotolo S
    Surg Oncol; 2020 Sep; 34():270-275. PubMed ID: 32891341
    [TBL] [Abstract][Full Text] [Related]  

  • 18. No Renal Toxicity After Repeated Treatment with Pressurized Intraperitoneal Aerosol Chemotherapy (PIPAC) in Patients with Unresectable Peritoneal Metastasis.
    Larbre V; Alyami M; Mercier F; Vantard N; Bonnefoy I; Opsomer MA; Villeneuve L; Bakrin N; Rioufol C; Glehen O; Kepenekian V
    Anticancer Res; 2018 Dec; 38(12):6869-6875. PubMed ID: 30504403
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cost-effectiveness analysis of pressurized intraperitoneal aerosol chemotherapy (PIPAC) in patients with gastric cancer and peritoneal metastasis.
    Javanbakht M; Mashayekhi A; Branagan-Harris M; Horvath P; Königsrainer A; Reymond MA; Yaghoubi M
    Eur J Surg Oncol; 2022 Jan; 48(1):188-196. PubMed ID: 34479745
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Occupational Exposure during Intraperitoneal Pressurized Aerosol Chemotherapy Using Doxorubicin in a Pig Model.
    Jung W; Park M; Park SJ; Lee EJ; Kim HS; Chung SH; Yoon C
    Saf Health Work; 2023 Jun; 14(2):237-242. PubMed ID: 37389318
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.